FAP and Cachexia: Depletion of FAP+ cells using genetic strategies resulted in a cachexia and anemia phenotype in mice (Roberts et al., 2013), underscoring that strategies to target CAFs for anticancer therapies must also take into consideration the systemic side effects, such as the risk of developing cachexia, anemia and other paraneoplastic syndromes.